Alison Johnson

650 total citations
25 papers, 261 citations indexed

About

Alison Johnson is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alison Johnson has authored 25 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Otorhinolaryngology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alison Johnson's work include Head and Neck Cancer Studies (9 papers), Breast Cancer Treatment Studies (5 papers) and Brain Metastases and Treatment (4 papers). Alison Johnson is often cited by papers focused on Head and Neck Cancer Studies (9 papers), Breast Cancer Treatment Studies (5 papers) and Brain Metastases and Treatment (4 papers). Alison Johnson collaborates with scholars based in France, Switzerland and Luxembourg. Alison Johnson's co-authors include William W. Turner, Charles L. Hofacre, Juliette Thariat, Jean‐Jacques Parienti, Nicolas Aide, A. Batalla, George Emile, Angélique Da Silva, Y. Pointreau and Anne Floquet and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Alison Johnson

25 papers receiving 256 citations

Peers

Countries citing papers authored by Alison Johnson

Since Specialization

Citations

This map shows the geographic impact of Alison Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Johnson more than expected).

Fields of papers citing papers by Alison Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Johnson. The network helps show where Alison Johnson may publish in the future.

Co-authorship network of co-authors of Alison Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Johnson. A scholar is included among the top collaborators of Alison Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Johnson. Alison Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NIVOPOSTOP (GORTEC 2018-01): A phase III randomized trial of adjuvant nivolumab added to radio-chemotherapy in patients with resected head and neck squamous cell carcinoma at high risk of relapse. 2025 ·Journal of Clinical Oncology ·(unknown), Anne Aupérin, Christian Borel, G. Lefebvre, S. Racadot, Lionnel Geoffrois, Xu Sun, Esma Saâda, Beatriz Cirauqui, Tomasz Rutkowski, Stéphanie Henry, A. Modesto, Alison Johnson, (unknown), Y. Pointreau, Elísabeth Pérez-Ruiz, Joanna Kaźmierska, Amanda Psyrri, Ricard Mesı́a, Yungan Tao, (unknown)	10
2	Impact of Radiation Therapy Modalities on Loco-regional Control in Inflammatory Breast Cancer 2024 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Youlia Kirova, (unknown), (unknown), Alison Johnson, (unknown), Eleonor Rivin del Campo, (unknown), (unknown), A. Mervoyer, (unknown), S. Thureau, Juliette Thariat	2
3	The impact of introducing deep learning based [18F]FDG PET denoising on EORTC and PERCIST therapeutic response assessments in digital PET/CT 2024 ·EJNMMI Research ·(unknown), (unknown), Alison Johnson, (unknown), Aurélie Parzy, Elodie Coquan, Charline Lasnon	3
4	Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors 2023 ·Frontiers in Oncology ·(unknown), George Emile, Alison Johnson, Christelle Lévy, Djelila Allouache, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Justine Lequesne, Angélique Da Silva	10
5	855MO Adjuvant immunotherapy after salvage surgery in head and neck cancer squamous cell carcinoma (HNSCC): Phase II trial evaluating the efficacy and the toxicity of Nivolumab (ADJORL1) 2023 ·Annals of Oncology ·Joanne Guerlain, Nathalie Cozic, Amaury Daste, O. Malard, Jérôme Fayette, Frédéric Rolland, Olivier Mauvais, Alison Johnson, Sébastien Salas, (unknown), Alexandre Bozec, S. Vergèz, Erwan de Monès, Ingrid Breuskin, (unknown), (unknown), François Janot, Caroline Even	3
6	HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer 2022 ·BMC Cancer ·(unknown), Angélique Da Silva, Alison Johnson, Cécile Blanc‐Fournier, (unknown), (unknown), Christelle Lévy, Djelila Allouache, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Justine Lequesne, George Emile	12
7	A priori quality assurance using a benchmark case of the randomized phase 2 GORTEC 2014-14 in oligometastatic head and neck cancer patients 2021 ·Cancer/Radiothérapie ·(unknown), C. Dejean, M. Bosset, Y. Pointreau, Rémy Kinj, S. Racadot, J. Castelli, F. Huguet, Sophie Renard, S. Guihard, Yungan Tao, Jorge Rouvier, Alison Johnson, Jean Bourhis, (unknown), Juliette Thariat	5
8	ACOSOG Z-0011 criteria impact on axillary surgery for early breast cancer in clinical practice: Evaluation in a retrospective cohort of 1900 patients 2021 ·European Journal of Obstetrics & Gynecology and Reproductive Biology ·(unknown), (unknown), Alison Johnson, (unknown), (unknown), F. Dravet, (unknown), Jean‐Marc Classe	1
9	Flap delineation guidelines in postoperative head and neck radiation therapy for head and neck cancers 2020 ·Radiotherapy and Oncology ·Jennifer Le Guévelou, Vianney Bastit, Pierre Yves Marcy, (unknown), (unknown), (unknown), (unknown), Alexandre Coutté, Arnaud Beddok, Valentin Calugaru, Alison Johnson, B. Géry, X. Liem, Y. Pointreau, Jean Bourhis, Juliette Thariat	13
10	Efficacy and Safety of Weekly Paclitaxel in Breast Cancer With Symptomatic Bone Marrow Infiltration 2020 ·Anticancer Research ·Angélique Da Silva, Christelle Lévy, Djelila Allouache, (unknown), (unknown), (unknown), (unknown), Alison Johnson, (unknown), Idlir Licaj, Gandhi Damaj, George Emile	1
11	917MO TOPNIVO - A safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of head and neck (R/M SCCHN): Final analysis 2020 ·Annals of Oncology ·Caroline Even, Amaury Daste, Jérôme Fayette, G. Lefebvre, Esma Saâda-Bouzid, Sylvie Zanetta, (unknown), Didier Cupissol, Sébastien Salas, (unknown), Alison Johnson, Élodie Vauléon, C. Le Tourneau, Clément Sire, (unknown), (unknown), Jean Bourhis, J. Guigay, A. Aupérin, (unknown)	1
12	Radiation therapy on primary tumour of synchronous metastatic head and neck squamous cell carcinomas 2020 ·Cancer/Radiothérapie ·(unknown), (unknown), Florian Clatot, (unknown), Alison Johnson, (unknown), Yungan Tao, Juliette Thariat	7
13	Traitements systémiques du carcinome adénoïde kystique de la sphère ORL localement avancé ou métastatique, une revue systématique 2019 ·Bulletin du Cancer ·(unknown), (unknown), Alison Johnson, (unknown), B. Géry, E. Babin, Juliette Thariat	6
14	Platinum rechallenge in recurrent head and neck squamous cell carcinoma after primary chemoradiation 2019 ·European Annals of Otorhinolaryngology Head and Neck Diseases ·(unknown), Idlir Licaj, B. Géry, R. Gervais, (unknown), E. Babin, D. De Raucourt, Alison Johnson, Juliette Thariat	6
15	Superior efficacy and similar safety of double dose anakinra in Erdheim-Chester disease after single dose treatment 2018 ·OncoImmunology ·(unknown), Samuel Deshayes, Hubert de Boysson, S. Trad, Nicolas Martin Silva, Benjamin Terrier, Boris Bienvenu, Françoise Galateau-Sallé, Jean‐François Emile, Alison Johnson, Achille Aouba	5
16	Uptake of Radium-223 Dichloride and Early [18F]NaF PET Response Are Driven by Baseline [18F]NaF Parameters: a Pilot Study in Castration-Resistant Prostate Cancer Patients 2017 ·Molecular Imaging and Biology ·(unknown), Alison Johnson, (unknown), (unknown), A. Batalla, Jean‐Jacques Parienti, Nicolas Aide	17
17	Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: a retrospective study 2017 ·BMC Cancer ·Alison Johnson, Margarida Matias, Helen Boyle, Bernard Escudier, (unknown), Brigitte Laguerre, Carole Hélissey, Pierre-Emmanuel Brachet, Audrey Emmanuelle Dugué, Loı̈c Mourey, Elodie Coquan, Florence Joly	5
18	Identification of I1171N resistance mutation in ALK-positive non-small-cell lung cancer tumor sample and circulating tumor DNA 2016 ·Lung Cancer ·Alison Johnson, Pascal Dô, Nicolas Richard, Cathérine Dubos, Jean Jacques Michels, Jessica Bonneau, Radj Gervais	8
19	Dieulafoy lesion of the appendix 2014 ·Digestive and Liver Disease ·Alison Johnson, (unknown), (unknown)	8
20	Effect of a Commercial Competitive Exclusion Culture on Reduction of Colonization of an Antibiotic-Resistant Pathogenic Escherichia coli in Day-Old Broiler Chickens 2002 ·Avian Diseases ·Charles L. Hofacre, Alison Johnson, (unknown), (unknown)	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact